Scientific Sessions

 

 

Register

 

Scientific Sessions

The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be available closer to the conference.

Plenary Sessions

10:30 - 11:15 a.m.

Association Welcome

Session: PL-01-01


11:15 - 11:45 a.m.

Aberrant Network Activity in Alzheimer’s Disease – Preclinical Investigation to Clinical Trials

Lennart Mucke, M.D.
Gladstone Institute of Neurological Disease, United States
Theme: Therapeutics
Session: PL-01-02


10:30 – 11 a.m.

Multimodal Lifestyle Interventions

Miia Kivipelto, Ph.D.
Karolinska Institutet; Karolinska University Hospital, Sweden
Theme: Therapeutics
Session: PL-02-01


11 - 11:30 a.m.

The Aging Brain and the Risk for Alzheimer’s Disease

Denise Park, Ph.D.
The University of Texas, Dallas, United States
Theme: Diagnosis and Prognosis
Session: PL-02-02


10:30 - 11 a.m.

The Winds of Change: Transformative Data Resources for Alzheimer’s Research

Richard Hodes, M.D.
National Institute on Aging, United States
Theme: Public Health and Psychosocial / Health Economics and Policy
Session: PL-03-01


11 - 11:30 a.m.

Psychosocial Research in Dementia: Past, Present and Future

Henry Brodaty, M.D.
UNSW Sydney, Australia
Theme: Public Health and Psychosocial
Session: PL-03-02


10:30 - 11 a.m.

Pathobiology of ApoE in Alzheimer’s Disease

Guojun Bu, Ph.D.
Mayo Clinic, United States
Theme: Diagnosis and Prognosis
Session: PL-04-01


11 - 11:30 a.m.

Communication Between the Immune System and the Brain

Michal Schwartz, Ph.D.
Weizmann Institute of Science, Israel
Theme: Basic and Translational Science
Session: PL-04-02


10:30 - 11:00 a.m.

Pathogenesis of Alzheimer's Disease: What Have We Learned From Neuroimaging?

Gil Rabinovici, M.D.
Memory and Aging Center, University of California, San Francisco, United States
Theme: Diagnosis and Prognosis
Session: PL-05-01


11:00 - 11:30 a.m.

AD Biomarker Epidemiology in the Aging Population: Prevalence, Risk Factors and Outcomes

Prashanthi Vemuri, Ph.D.
Mayo Clinic, United States
Theme: Public Health & Psychosocial
Session: PL-05-02



Symposium Sessions

Sunday, July 22
  • 8 - 9:30 a.m.
    Innovative Approaches In Epidemiology
    Theme: Public Health and Psychosocial Factors / Epidemiology
    Session S1-01

PRESENTATIONS

SPEAKERS


Approaches to Harmonize Neuropsychological Data Across Studies

Nicole Kochan
Centre for Healthy Brain Ageing, UNSW;
Neuropsychiatric Institute, Prince of Wales Hospital, Australia


Alternatives to Randomized Trials Using Simulations and Observational Data

Chung-Chou Chang
University of Pittsburgh
Graduate School of Public Health, United States


Analysis of Data from Wearable Devices

Aron Buchman
Rush Alzheimer's Disease Center;
Rush University Medical Center, United States


Epidemiology in the Era of Big Data

Robert Stewart
King’s College
London, United Kingdom


Sunday, July 22
  • 8 - 9:30 a.m.
    Genetic and Biological Validation of Alzheimer GWAS Genes and Their Contribution to Disease
    Theme: Basic and Translational Science / Genetics
    Session: S1-02

PRESENTATIONS

SPEAKERS


Review of GWAS Genes and Polygenic Risk Scores

Carlos Cruchaga
Washington University
School of Medicine, United States


Approaches Towards Understanding the Pathomechanism Underlying GWAS Gene Associations

Steven Estus
Sanders-Brown
Center on Aging, United States


Genetics of SORL1 and Its Role As APP Neuronal Sorting Receptor

Ekaterina Rogaeva
University of Toronto, Canada


Complex Mutations in ABCA7 Modify Disease Penetrance By Dosage Reduction

Kristel Sleegers
Institute Born-Bunge,
University of Antwerp;
Neurodegenerative Brain Diseases Group,
Center for Molecular Neurology, VIB, Belgium


Monday, July 23
  • 8 - 9:30 a.m.
    Linking Neuroimaging To Neuropathology Of Tau
    Theme: Diagnosis and Prognosis / Neuroimaging
    Session: S2-01

PRESENTATIONS

SPEAKERS


Tau Pathology of Alzheimer's Disease

Charles Duyckaerts
Laboratoire de neuropathologie
Raymond Escourolle, France


Origins of Tau Accumulation

Lea Grinberg
University of California,
San Francisco, United States;
University of São Paulo Medical School, Brazil


Linking Post-Mortem MRI and Dense Histology

Paul Yushkevich
Penn Image Computing and Science Laboratory (PICSL),
University of Pennsylvania, United States


Tau Dissemination Patterns in the Brain Before and After Dementia

Val Lowe
Mayo Clinic, United States


Monday, July 23
  • 8 - 9:30 a.m.
    Translational Research In Reality—What Are The Criteria From Concept To Clinic?
    Theme/Topic: Therapeutics / Clinical
    Session: S2-02

PRESENTATIONS

SPEAKERS


New In Vivo Models for Alzheimer’s Disease – MODEL-AD

Bruce Lamb
Indiana University,
Stark Neurosciences Research Institute, United States


Translational Research – The View from Pharma

Samantha Budd Haeberlein
Biogen, United States


Progression of Synaptoprotective Sigma-2 Antagonists into the Clinic

Susan Catalano
Cognition Therapeutics Inc., United States


Targeting the p75 Neurotrophin Receptor – A New Approach for Alzheimer’s Disease

Frank Longo
Stanford University, United States


Tuesday, July 24
  • 8 - 9:30 a.m.
    Apolipoprotein E & Dementia: Mechanisms, Risk And Therapy
    Theme/Topic: Diagnosis and Prognosis / Neuropathology
    Session: S3-01

PRESENTATIONS

SPEAKERS


Effects of ApoE on Tau Mediated Neurodegeneration

David Holtzman
Washington University, United States


Apoe and Alzheimer’s Disease Imaging Biomarkers

Beth Mormino
Stanford University, United States


Apoe and Sex Differences on Alzheimer’s Disease Risk

Arthur Toga
University of Southern California, United States


Therapeutic Strategies: Apoe in Traumatic Brain Injury

Cheryl Wellington
University of British Columbia, Canada


Tuesday, July 24
  • 8 - 9:30 a.m.
    Mechanisms Of Neuronal Death
    Theme/Topic: Therapeutics / Preclinical (nonhuman)
    Session: S3-02

PRESENTATIONS

SPEAKERS


Necroptosis Activation in Alzheimer’s Disease

Antonella Caccamo
Arizona State University, United States


Stress Granule Formation and Neuronal Death

Benjamin Wolozin
Boston University School of Medicine, United States


Neuroinflammatory Processes and Neurodegeneration

Roisin McManus
German Center for Neurodegenerative Diseases (DZNE), Germany


Microglial Activation in Neurodegenerative Diseases: Opportunities for Therapeutic Intervention

Diego Gomez-Nicola
University of Southampton, United Kingdom


Wednesday, July 25
  • 8 - 9:30 a.m.
    Environmental Risk Factors For Alzheimer’s Disease
    Theme/Topic: Public Health and Psychosocial Factors / Psychosocial Factors and Environmental Design
    Session: S4-01

PRESENTATIONS

SPEAKERS


The Relation Between Air Pollution Exposure and Dementia

Jennifer Weuve
Boston University School of Public Health, United States


Interaction between Pollutant Exposures and Genetics in Aging Populations at Risk for Cognitive Decline

Kelly Bakulski
University of Michigan, United States


Life Course Air Pollution Exposure and Cognitive Decline in Scotland: Modelled Historical Air Pollution Data and the Lothian Birth Cohort 1936

Tom Russ
University of Edinburgh,
United Kingdom


Traffic Noise Exposure and Mild Cognitive Impairment

Lilian Tzivian
University of Lativia, Lativia


Thursday, July 26
  • 8:30 – 10 a.m.
    Role of Glial Cells in Neurodegeneration
    Theme/Topic: Basic and Translational Science / Molecular and Cell Biology
    Session: S5-01

PRESENTATIONS

SPEAKERS


Ageing and Neuroimmunology: The White Matter Pathology

Julie Simpson
University of Sheffield, United Kingdom


Astrocytes in Alzheimer’s Disease - Molecular Changes and Functional Consequences

Elly Hol
Brain Center Rudolf Magnus,
UMC Utrecht, Netherlands


Microglia: Dynamic Sensors of Neural Activity

Caroline Baufeld
Brigham and Women's Hospital,
United States


Oligodendrocytes in Dementia

Ragnhildur Thora Karadottir
University of Cambridge,
United Kingdom




Join the Conversation #AAIC18

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs